Dr. Reddy's Laboratories Limited (RDY) - Moat Analysis

Valuation

3.4/5

3.44

Measures whether the stock is cheap or expensive across earnings, assets, enterprise value, and cashflow multiples.

Sub-dimension

Summary

Score

Earnings Valuation

3.75

Price relative to earnings power

3.75

Summary

• stands at 17.8, below the sector average (23.0)
• - no data available

3.75

Asset Valuation

4.44

Price relative to net asset value

4.44

Summary

• stands at 2.90, well below the sector average (6.00)
• stands at 3.03, well below the sector average (7.50)

4.44

Enterprise Valuation

3.74

Enterprise value relative to operating earnings

3.74

Summary

• stands at 12.0, well below the sector average (18.0)
• stands at 3.18, well below the sector average (7.50)
• stands at 18.5, above the sector average (15.0)

3.74

Cashflow Valuation

1.72

Price relative to free cashflow generation

1.72

Summary

• stands at 49.3, well above the sector average (28.0)
• stands at 0.021, well below the sector average (0.040)

1.72

Financial Health

4.0/5

4.00

Assesses balance-sheet strength through liquidity, leverage, and interest coverage ratios.

Sub-dimension

Summary

Score

Liquidity

2.75

Ability to meet short-term obligations

2.75

Summary

2.75

Leverage

4.99

Debt load relative to equity and assets

4.99

Summary

4.99

Coverage

4.09

Earnings vs interest expense

4.09

Summary

4.09

Full analysis requires login